APA (7th ed.) Citation

Wu, Y., Sun, X., Lv, L., Cui, Q., Qian, J., Xing, R., . . . Liu, Y. (2025, June). Efficacy of individualized orelabrutinib-based regimens in relapsed or refractory central nervous system lymphoma. Frontiers in Neurology.

Chicago Style (17th ed.) Citation

Wu, Yuchen, et al. "Efficacy of Individualized Orelabrutinib-based Regimens in Relapsed or Refractory Central Nervous System Lymphoma." Frontiers in Neurology Jun. 2025.

MLA (9th ed.) Citation

Wu, Yuchen, et al. "Efficacy of Individualized Orelabrutinib-based Regimens in Relapsed or Refractory Central Nervous System Lymphoma." Frontiers in Neurology, Jun. 2025.